Chemistry:XXB 750

From HandWiki
Short description: Experimental drug


XXB 750 is an experimental injected drug that targets natriuretic peptide (NPR1) and is developed to treat resistant hypertension.[1][2] It was also tried for heart failure with reduced ejection fraction.[3]

References

  1. ↑ Janakiraman, Arun; Cohen, Debbie L. (27 September 2023). "New Potential Treatments for Resistant Hypertension". Current Cardiology Reports. doi:10.1007/s11886-023-01966-8. 
  2. ↑ "XXB 750 - AdisInsight". https://adisinsight.springer.com/drugs/800068209. 
  3. ↑ "Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)". https://ichgcp.net/clinical-trials-registry/NCT05328752. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:XXB_750&oldid=3323015"